![]() |
市場調查報告書
商品編碼
2088818
床邊超音波診斷設備市場:2026-2032年全球市場預測(按系統類型、影像技術、運算架構、應用和最終用戶分類)Point Of Care Ultrasound Systems Market by System Type, Imaging Technology, Computing Architecture, Application, End-User - Global Forecast 2026-2032 |
||||||
※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。
預計到 2032 年,即時超音波診斷設備市場將成長至 73.7 億美元,複合年成長率為 8.94%。
| 主要市場統計數據 | |
|---|---|
| 基準年 2025 | 40.5億美元 |
| 預計年份:2026年 | 43.9億美元 |
| 預測年份 2032 | 73.7億美元 |
| 複合年成長率 (%) | 8.94% |
床邊超音波系統正在改變我們進行診斷影像的方式,將即時視覺化從中心放射科轉移到急診室、加護病房、救護車、社區診所和醫生辦公室。這一領域的發展動力源於臨床上對更快速分診、無輻射成像、攜帶式診斷和低成本診療路徑的迫切需求,尤其是在床邊即時資訊能夠改變患者治療策略的情況下。
在醫療系統面臨許多挑戰的地區,例如急診科擁擠、醫生短缺、孕產婦保健需求旺盛、創傷患者負擔沉重、人口老化以及慢性病高發等,這項技術的應用最為廣泛。手持式和推車式超音波平台目前已應用於急診醫學、循環系統、婦產科、麻醉學、基層醫療、肌肉骨骼醫學、血管通路和重症監護等領域,使得床邊超音波成為醫療設備製造商、數位醫療供應商、醫療服務提供者和保險公司最為關注的領域。
該領域正從固定的成像基礎設施轉向分散式、高度互聯且與工作流程整合的超音波。可攜式探頭、平板電腦主機、雲端存檔、無線連接、電池供電設計以及簡化的預設功能,正在減少對專用成像室的依賴,並支援在急診環境中快速進行床邊決策。
人工智慧 (AI) 正逐漸成為床邊超音波系統的實用差異化優勢,它能夠支援影像擷取、自動測量、解剖引導、影像品質評估、工作流程優先排序和臨床決策支援。獲得 FDA 批准的 AI超音波工具已在市場中佔據主導地位,尤其是在心臟評估、產科測量、肺部超音波、膀胱容量估算、血管通路和手術引導等領域。
北美仍然是床邊超音波系統的主要市場,這得益於其在急診醫學領域的高普及率、完善的保險報銷和超音波檢查編碼機制、強大的醫院採購能力、FDA的監管以及在急診、門診和居家照護模式中不斷擴展的應用。歐洲則受益於成熟的醫院基礎設施、歐盟醫療設備法規(EU MDR)下的跨境醫療器材監管,以及超音波、重症監護、急診醫學、肌肉骨骼疾病治療和基層醫療分診等領域對超音波日益成長的需求。互通性、資料保護和臨床證據要求也日益影響採購決策。
在東南亞國協,隨著各國政府擴大基層醫療、孕產婦保健的範圍,加強急救服務,並發展本地診斷系統,對價格適中的手持式和推車式超音波診斷設備的需求日益成長。海灣合作理事會(GCC)地區的特點是醫院採購高階設備,快速投資於數位醫療領域,推行集中化的醫療轉型計劃,以及急診、循環系統、產科、麻醉科和重症監護科對聯網超音波診斷設備的需求。
美國在急診醫學、麻醉學、重症監護、循環系統、產科和門診護理等領域的臨床應用方面處於主導地位,而加拿大則側重於標準化培訓、農村地區的普及、對原住民和偏遠社區的護理以及公立醫院的採購。在墨西哥和巴西,由於都市區醫院的現代化以及將影像服務擴展到大型三級醫療中心以外的需求,公私可攜式醫療機構對攜帶式系統的需求正在成長。在英國、德國、法國、義大利和西班牙,床邊超音波(POCUS)正透過急診醫學、重症監護、麻醉學和基層醫療等措施推廣,其應用受到臨床管治、資料安全、培訓路徑和公共醫療系統優先事項的影響。同時,在俄羅斯,由於醫院影像服務的現代化以及對專科診斷的需求,對床邊超音波的需求仍然強勁。
產業領導者應檢驗經過臨床驗證的手持式和推車式系統,這些系統應兼具影像品質、易用性、耐用硬體、感染控制功能、資料安全性和與電子病歷 (EHR)、影像歸檔和通訊系統 (PACS) 以及雲端平台的無縫連接。產品藍圖應包括人工智慧驅動的指導、自動測量、專業預設、認證支援、遠端整合和培訓模組,以減少操作人員之間的差異。
本執行摘要基於對公開可用的循證來源的系統性審查,包括資訊來源資料庫、臨床學會指南、醫院採用趨勢、同行評審的超音波研究、醫療保健基礎設施指標、保險報銷狀況、公共衛生優先事項和醫療設備業資訊披露。
床邊超音波(POCUS)系統正從專用工具發展成為急診、門診和資源匱乏環境中不可或缺的診斷平台。便攜性、人工智慧驅動的易用性、企業級連接性、更廣泛的臨床醫生培訓以及對快速床邊決策日益成長的需求,都促進了POCUS在整個醫療保健系統中發揮越來越重要的臨床作用。
The Point Of Care Ultrasound Systems Market is projected to grow by USD 7.37 billion at a CAGR of 8.94% by 2032.
| KEY MARKET STATISTICS | |
|---|---|
| Base Year [2025] | USD 4.05 billion |
| Estimated Year [2026] | USD 4.39 billion |
| Forecast Year [2032] | USD 7.37 billion |
| CAGR (%) | 8.94% |
Point-of-care ultrasound systems are reshaping diagnostic imaging by moving real-time visualization from centralized radiology departments to emergency rooms, intensive care units, ambulances, rural clinics, and physician offices. The category is supported by documented clinical demand for faster triage, radiation-free imaging, portable diagnostics, and lower-cost care pathways, particularly where immediate bedside information can change patient management.
Adoption is strongest where health systems face emergency department crowding, physician shortages, maternal health needs, trauma burden, aging populations, and chronic disease prevalence. Handheld and cart-based ultrasound platforms now support applications across emergency medicine, cardiology, obstetrics and gynecology, anesthesiology, primary care, musculoskeletal care, vascular access, and critical care, making point-of-care ultrasound a high-priority category for medical device manufacturers, digital health vendors, providers, and payers.
The landscape is shifting from fixed imaging infrastructure toward decentralized, connected, and workflow-integrated ultrasound. Portable probes, tablet-based consoles, cloud archiving, wireless connectivity, battery-powered designs, and simplified presets are reducing dependence on dedicated imaging suites and enabling faster bedside decision-making in acute and longitudinal care settings.
Regulatory and clinical practice developments are also accelerating adoption. Organizations such as the American College of Emergency Physicians, the American Institute of Ultrasound in Medicine, and multiple specialty societies have expanded guidance on point-of-care ultrasound training, credentialing, quality assurance, documentation, and appropriate use, while hospitals are increasingly linking ultrasound images to electronic health records and PACS environments to support governance and continuity of care.
Artificial intelligence is becoming a practical differentiator in point-of-care ultrasound systems by supporting image acquisition, automated measurements, anatomy guidance, image quality scoring, workflow prioritization, and clinical decision support. FDA-cleared AI-enabled ultrasound tools already demonstrate the direction of the market, particularly in cardiac assessment, obstetric measurements, lung ultrasound, bladder volume estimation, vascular access, and procedural guidance.
The cumulative impact is improved usability for non-radiologist clinicians, reduced scan variability, faster interpretation, and broader access in settings with limited sonographer availability. However, leaders must manage model validation, cybersecurity, bias monitoring, explainability, data privacy, human oversight, and clinical governance before scaling AI-enabled ultrasound across enterprise networks.
North America remains a leading region for point-of-care ultrasound systems due to high emergency medicine adoption, established reimbursement and coding pathways for many ultrasound procedures, strong hospital purchasing capacity, FDA oversight, and growing use in urgent care, outpatient clinics, and home-based care models. Europe benefits from mature hospital infrastructure, cross-border medical device regulation under EU MDR, and increasing demand for ultrasound in anesthesia, intensive care, emergency medicine, musculoskeletal care, and primary care triage, with procurement decisions increasingly shaped by interoperability, data protection, and clinical evidence requirements.
Asia-Pacific is expanding rapidly as China, India, Japan, South Korea, and Australia invest in hospital modernization, maternal health, aging-population care, rural diagnostic access, and digital health infrastructure. Latin America shows rising demand in Brazil and Mexico, where portable ultrasound supports public health systems, private clinics, emergency departments, and obstetric care. The Middle East is driven by hospital expansion, medical tourism, specialist care investment, and GCC digital health programs, while Africa is increasingly adopting handheld ultrasound to address maternal mortality, infectious disease complications, trauma care, limited radiology access, and specialist shortages in district hospitals and community settings.
ASEAN countries are increasing demand for affordable handheld and cart-based ultrasound as governments expand primary care coverage, maternal care, emergency medicine capacity, and rural diagnostics. The GCC is characterized by premium hospital procurement, rapid digital health investment, centralized healthcare transformation programs, and demand for connected ultrasound in emergency, cardiology, obstetrics, anesthesia, and critical care departments.
The European Union is shaped by EU MDR compliance, interoperability requirements, data protection rules, and value-based procurement, while BRICS economies create scale opportunities through public hospital modernization, large patient populations, domestic manufacturing ambitions, and broad demand for accessible diagnostic imaging. G7 markets are early adopters of AI-enabled and enterprise-connected ultrasound, supported by advanced clinical training ecosystems, robust regulatory oversight, and established digital health infrastructure. NATO member countries also show growing use of portable ultrasound in military medicine, trauma stabilization, disaster response, aeromedical evacuation, and field hospitals where rapid imaging can support time-sensitive decisions.
The United States leads in clinical adoption across emergency medicine, anesthesia, critical care, cardiology, obstetrics, and ambulatory care, while Canada emphasizes standardized training, rural access, Indigenous and remote community care, and public hospital procurement. Mexico and Brazil show growing demand for portable systems in mixed public-private healthcare environments, supported by urban hospital modernization and the need to extend imaging beyond major tertiary centers. The United Kingdom, Germany, France, Italy, and Spain are expanding POCUS through emergency medicine, intensive care, anesthesia, and primary care initiatives, with procurement influenced by clinical governance, data security, training pathways, and public health system priorities, while Russia maintains demand tied to hospital imaging modernization and specialist diagnostics.
China is scaling ultrasound through large hospital networks, domestic device capabilities, and government-backed healthcare capacity expansion. India is using portable ultrasound to strengthen maternal health, rural diagnostics, emergency care, and private clinic imaging, while Japan prioritizes high-quality imaging, aging-population care, compact systems, and workflow efficiency. Australia supports POCUS adoption in remote medicine, emergency care, retrieval services, and rural hospitals, and South Korea is advancing connected ultrasound through strong medtech capabilities, digitally mature hospitals, and demand for high-performance compact imaging platforms.
Industry leaders should prioritize clinically validated handheld and cart-based systems that combine image quality, ease of use, durable hardware, infection-control readiness, data security, and seamless connectivity with EHR, PACS, and cloud platforms. Product roadmaps should include AI guidance, automated measurements, specialty-specific presets, credentialing support, remote collaboration, and training modules that reduce operator variability.
Commercial teams should align with emergency medicine, critical care, obstetrics, primary care, cardiology, anesthesia, and procedural specialties while tailoring pricing models for hospitals, outpatient networks, academic centers, military medicine, and resource-limited settings. Organizations that invest in clinical evidence, post-market surveillance, reimbursement education, cybersecurity, service reliability, local regulatory expertise, and user education will be best positioned for sustainable adoption.
This executive summary is developed from a structured review of publicly available, evidence-based sources, including regulatory databases, clinical society guidance, hospital adoption trends, peer-reviewed ultrasound research, healthcare infrastructure indicators, reimbursement context, public health priorities, and medical device industry disclosures.
The methodology emphasizes triangulation across primary clinical use cases, regional healthcare capacity, regulatory requirements, technology adoption, training standards, and product capability trends. Insights are validated through consistency checks across authoritative sources such as FDA communications, specialty society publications, WHO health system indicators, EU medical device policy, national digital health strategies, and healthcare modernization programs.
Point-of-care ultrasound systems are moving from specialty tools to essential diagnostic platforms across acute, ambulatory, and resource-limited care. The combination of portability, AI-enabled usability, enterprise connectivity, expanding clinician training, and growing demand for faster bedside decisions is strengthening the clinical role of POCUS across healthcare systems.
Market success will depend on evidence-backed performance, workflow integration, regulatory readiness, cybersecurity, training quality, and affordability. Vendors and healthcare organizations that treat POCUS as a connected clinical ecosystem rather than a standalone device will be best positioned to deliver long-term clinical and operational value.